Implementation research to explore operational feasibility, acceptability and cost-effectiveness of using IVFerric Carboxy Maltose (FCM) in Management of Iron Deficiency Anemia (IDA) among pregnant women through sub district health systemin Maharashtra

Department of health research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Diagnosed with iron deficiency anemia with hemoglobin levels between 5- 9.9gm/dl between 22-32 weeks of gestational age with following criteria
•Severe anemia with hemoglobin <7 gms anytime between 22-32 weeks
•Moderate anemia with hemoglobin between 7-9.9 gms during 22-28 weeks not responding to oral iron given for 6 weeks
•Moderate anemia in last trimester irrespective of previous iron intake.
•Willing to sign an informed consent, deliver at the same site and willing for follow up

•Ã¢â?¬Â¢Pregnant women with hemoglobin levels below 5gm/dl and above 9.9 gm/dl in the first or second trimester of pregnancy.
•Ã¢â?¬Â¢Pregnant women diagnosed with anemia other than iron deficiency anemia based on peripheral smear examination and red cell indices, picture suggestive of pancytopenia,
•Ã¢â?¬Â¢Any known cases of hemoglobinopathies or with Pregnancy Induced Hypertension
•Ã¢â?¬Â¢ History of iron overload disorder (Thalassemia, hemochromatosis, hemosiderosis]
•Ã¢â?¬Â¢Pregnant women with known cardiac, renal, hepatic disease
•Ã¢â?¬Â¢Pregnant women having associated medical disorders like hypertension, asthma, tuberculosis, heart disease rheumatic or congenital heart disease), heart failure or cardiac decompensation,
•Ã¢â?¬Â¢history of intravenous iron therapy in the past 6 months or history of repeated blood transfusions
•Ã¢â?¬Â¢Pregnant women with known OR history of hypersensitivity to ferric carboxy-maltose or iron sucrose
•Ã¢â?¬Â¢Pregnant women in labor
•Ã¢â?¬Â¢Blood loss due to hemodynamic instability
•Ã¢â?¬Â¢History of malignancy, GI bleed, surgery
•Ã¢â?¬Â¢suspected acute infections (such as upper respiratory tract infections, urinary tract infections, or fever at the time of visit), h/o of rashes and fever during pregnancy to rule rubella)

发起方

Department of health research